A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : OS / observed survival

[Related PubMed/MEDLINE]
Total Number of Papers: 17
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   OS  (>> Co-occurring Abbreviation)
Long Form:   observed survival
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Predicting Survival for Patients With Metastatic Disease. ---
2019 Analysis of Mortality and Survival Rate of Liver Cancer in Zhejiang Province in China: A General Population-Based Study. RS
2019 Association between surgical volume and post-operative mortality and survival after surgical resection in lung cancer in Belgium: Apopulation-based study. NSCLC
2018 Cancer survival in patients from a hospital-based cancer registry, China. HBCR
2018 Childhood and adolescent lymphoma in Spain: incidence and survival trends over 20years. ACCIS, BL, HL, NHL
2017 Malignant and borderline epithelial ovarian tumors in the pediatric and adolescent population. BOT, EOC
2015 Gender and ethnic differences in incidence and survival of lymphoid neoplasm subtypes in an Asian population: Secular trends of a population-based cancer registry from 1998 to 2012. ASIRs, CLL, LN, RSR, SCR, SLL, WHO
2015 Is melanoma survival influenced by month of diagnosis? BCR, CI, RS
2014 Common cancers in centenarians. KM, SEER
10  2014 Female breast cancer survival in Qidong, China, 1972-2011: a population-based study. RS
11  2014 TNM staging of colorectal cancer should be reconsidered by T stage weighting. TNM
12  2014 [Long-term survival trends for liver cancer in Qidong: 1972 to 2011]. RS
13  2012 Incidence and survival of pediatric soft tissue sarcomas in moscow region, Russian Federation, 2000-2009. RMS, STSs
14  2009 Lymphadenectomy for patients with cervical cancer: is it of value? ES, LND, LNs, SEER
15  2008 Adjuvant brachytherapy removes survival disadvantage of local disease extension in stage IIIC endometrial cancer: a SEER registry analysis. BT, EBRT, RT, SEER
16  2006 Management of T3N1 glottic carcinoma: therapeutic outcomes. DSS, LP, ND, TL
17  2004 Management of stage IV glottic carcinoma: therapeutic outcomes. CDSS, DSS, RT, TL, TL/ND, TL/RT